Navigation Links
MiMedx Announces 2012 Results
Date:3/7/2013

business, and the expected quarterly revenue growth. These statements are based on current information and belief, and are not guarantees of future performance.  Among the risks and uncertainties that could cause actual results to differ materially from those indicated by such forward-looking statements include that the direct sales force strategy will not continue to produce quarter-over-quarter sales growth, that the clinical study results will not be as positive as anticipated or will not enable the Company to capture additional market presence, that a new patent will not issue in the near term  or that the claims, if any, allowed will be substantially reduced, that competitors can "design around" the Company's patents; that the Company may not be successful in entering into new placenta recovery contracts, that the Company's existing and future placental recovery contracts will not be sufficient to meet the Company's demand for tissue,  that the reimbursement coverage in the Medicare and commercial sectors does not materialize or expands at a rate slower than anticipated, that VA and government business will not continue to increase, that quarterly revenue growth will be below expectations, and the risk factors detailed from time to time in the Company's periodic Securities and Exchange Commission filings, including, without limitation, its 10-K filing for the fiscal year ended December 31, 2011. By making these forward-looking statements, the Company does not undertake to update them in any manner except as may be required by the Company's disclosure obligations in filings it makes with the Securities and Exchange Commission under the federal securities laws.

 MIMEDX GROUP, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF OPERATIONS Years Ended December 31,REVENUES:20122011Net sales$
27,053,773$
7,760,446OPERATING COSTS AND EXPENSES:Cost of products sold

5,188,3783,357,909Research and development expenses

'/>"/>
SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. MiMedx Group to Present at the 6th Annual OneMedForum
2. MiMedx Group to Present at the Stifel Nicolaus 2012 Healthcare Conference
3. CCS Medical Announces Agreement with LifeScan
4. HUYA Bioscience Announces Partnership With Shanghai Zhangjiang Biotech Pharmaceutical Base
5. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
6. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Impax Laboratories Inc.
7. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
8. DMH International Announces The Launch of TouchPACS
9. Psyche Systems Announces Availability of Toxicology LIS
10. Jazz Pharmaceuticals Announces Pricing Of Public Offering Of Ordinary Shares By Selling Shareholders
11. DDS Lab Announces Strategic Alliance with United Concordia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... ) has announced the addition of the ... report to their offering.      ... have been broadly classified into wide categories ... used for the treatment of different gynecological ...
(Date:9/19/2014)... Sept. 19, 2014  For Cloud Pharmaceuticals, Inc., ... and development, partnering is an integral part of ... design new drugs and identify early stage, preclinical, ... further their development. The company also partners with ... this business model, Cloud Pharmaceuticals will be participating ...
(Date:9/19/2014)... The American Association for Homecare (AAHomecare) is ... has joined the AAHomecare Corporate Partner Program. ... have been actively involved in AAHomecare for much of ... grown into a major global manufacturer of home medical ... to increase efforts on behalf of the HME sector ...
Breaking Medicine Technology:Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2
... CAMBRIDGE, Mass. , Aug. 4 ... therapies to treat autoimmune diseases and cancer by modulating ... Antonin (Tony) de Fougerolles , Ph.D., as Chief Scientific ... provide leadership for the company’s research and early-stage product ...
... , THE WOODLANDS, Texas , Aug. 3 ... LXRX ), a biopharmaceutical company focused on discovering breakthrough ... its second quarter 2010 financial results on Monday, August ... will hold a conference call to discuss its clinical development ...
Cached Medicine Technology:Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer 2Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer 3Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer 4Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2010 Financial Results 2
(Date:9/21/2014)... 21, 2014 Originally approved by ... GSK’s Flovent (fluticasone propionate) is a synthetic ICS ... for the maintenance treatment of asthma prophylactically in ... two formulations, Diskus and HFA, which received the ... active ingredient, fluticasone propionate, can bind to glucocorticoid ...
(Date:9/21/2014)... An experienced review website in the global ... list and announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy ... , There has been a boom in websites in ... an increase in the number of web hosting companies ... affordable prices. VPS (Virtual Private Server) is the method ...
(Date:9/21/2014)... OH (PRWEB) September 21, 2014 C8 ... District of Ohio as the list of 20 possible ... been narrowed down to six, reports Wright & Schulte ... chosen from the almost 2500 C8 lawsuits filed that ... or testicular cancer as a result of being exposed ...
(Date:9/20/2014)... Vegas, NV (PRWEB) September 21, 2014 ... by Dr. Kenneth Pullman that is helping thousands of ... their diabetes symptoms without shots, pills, or prescriptions has ... review. , “There are currently tens of millions ... both Type 1 and Type 2 diabetes, and unfortunately, ...
(Date:9/20/2014)... Baja, Mexico (PRWEB) September 20, 2014 ... announced the resort did not experience any damage in ... all amenities and activities available. , Hurricane Odile struck ... bringing intense wind, rain and powerful surf conditions. Located ... del Palmar Islands of Loreto experienced some heavy rain, ...
Breaking Medicine News(10 mins):Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 3Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 4Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3
... , , , ... JAZZ ) today announced financial results for the second quarter ended June ... quarter were $37.3 million, compared to $15.5 million for the quarter ended ... milestone payment from UCB Pharma Limited that was received in July 2008 ...
... , LAKEWOOD, Colo., Aug. 11 Mesa Laboratories, ... of Directors has declared a regular quarterly cash dividend of 10 ... to shareholders of record at the close of business on August ... manufactures and markets electronic instruments and disposables for industrial, pharmaceutical and ...
... VERNON HILLS, Ill., Aug. 11 Lifeline Vascular Access(SM), the ... the launch of the Lifeline Vascular Access Network(SM) - ... to deliver quality care and impact industry-wide health-care cost savings. ... money for end-stage renal disease (ESRD) patients and the entire ...
... , , , ... a worldwide manufacturer and distributor of agricultural equipment, today ... Norman L. Boyd, has been appointed by Governor Perdue ... of Community Health champions access to affordable, quality health ...
... , New Studies Show Healthy Lifestyle Habits ... WASHINGTON, Aug. 11 Though years ago everyone was looking for ... of chronic disease, scientific researchers today recognize that it is the ... a healthy diet, using dietary supplements and exercising regularly -- that ...
... who ate healthy and remained active were protected, study ... a Mediterranean diet, which emphasizes fruits, vegetables, legumes and ... the risk of developing Alzheimer,s disease, a new study ... 12 issue of the Journal of the American ...
Cached Medicine News:Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 2Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 3Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 4Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 5Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 6Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 7Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 8Health News:Lifeline Vascular Access Launches New Platform for Physicians to Share Best Practices and Improve Vascular Access Care 2Health News:AGCO Senior Executive, Norm Boyd, Receives Executive Appointment to Georgia's Board of Community Health by Georgia Governor Sonny Perdue 2Health News:Healthy Lifestyles Are 'In' - Magic Bullets Are 'Out' 2Health News:Healthy Lifestyles Are 'In' - Magic Bullets Are 'Out' 3Health News:Healthy Lifestyles Are 'In' - Magic Bullets Are 'Out' 4Health News:Mediterranean Diet Plus Exercise Lowers Alzheimer's Risk 2Health News:Mediterranean Diet Plus Exercise Lowers Alzheimer's Risk 3
... Electronic Medical Record system. It stores patient chart ... and everything you would normally put in a ... Someone has to write them, file them, find ... Paper Charts get lost. They find their way ...
... precision demands absolute knowledge. Access ... Lomb Zyoptix Diagnostic Workstation, uniting ... Wavefront Aberrometer and Orbscan IIz ... they supply critically important data. ...
ZYMAR™ ophthalmic solution is an anti-infective prescription eye drop that your doctor may instruct you to use if you have an eye infection caused by bacteria. Bacterial conjunctivitis is the e...
LUMIGAN® is a powerful eye drop medication for lowering IOP. IOP is short for intraocular pressure or eye pressure. LUMIGAN® is the first in a new class of medication....
Medicine Products: